Cargando…

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma

BACKGROUND: A comprehensive investigation of ubiquitin-conjugating enzyme E2I (UBE2I) in cancer is still insufficiency. In this study, we aimed to analyze its role and mechanism in cancer by combination of bioinformatic analysis and experimental validation. METHODS: The expression profile of UBE2I i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hao, Gao, Shan, Chen, Jing, Lou, Weiyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291483/ https://www.ncbi.nlm.nih.gov/pubmed/32536822 http://dx.doi.org/10.1186/s12935-020-01311-x

Ejemplares similares

Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer
por: Sun, Jingbo, et al.
Publicado: (2019)

Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma
por: Yan, Tao, et al.
Publicado: (2019)

Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma
por: Shao, Xuyang, et al.
Publicado: (2022)

MT1-MMP in breast cancer: induction of VEGF-C correlates with metastasis and poor prognosis
por: Yao, Guangyu, et al.
Publicado: (2013)

DSG2 expression is correlated with poor prognosis and promotes early-stage cervical cancer
por: Qin, Shuhang, et al.
Publicado: (2020)

Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients
por: Deng, Haifeng, et al.
Publicado: (2019)

ncRNAs-mediated high expression of SEMA3F correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma
por: Lou, Weiyang, et al.
Publicado: (2021)

RPLP1 promotes tumor metastasis and is associated with a poor prognosis in triple-negative breast cancer patients
por: He, Zhixian, et al.
Publicado: (2018)

Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression
por: Ren, Xiaoyue, et al.
Publicado: (2021)

Decreased RIG-I expression is associated with poor prognosis and promotes cell invasion in human gastric cancer
por: Chen, Lujun, et al.
Publicado: (2018)

FABP4 is an independent risk factor for lymph node metastasis and poor prognosis in patients with cervical cancer
por: Li, Guoqing, et al.
Publicado: (2021)

Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma
por: Cao, Zhongwei, et al.
Publicado: (2014)

SHC4 promotes tumor proliferation and metastasis by activating STAT3 signaling in hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2022)

Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
por: Lv, Lei, et al.
Publicado: (2020)

Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2014)

Upregulation of SNTB1 correlates with poor prognosis and promotes cell growth by negative regulating PKN2 in colorectal cancer
por: Liu, Liya, et al.
Publicado: (2021)

Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling
por: Hang, Chen, et al.
Publicado: (2021)

Upregulated expression of DIXDC1 in intestinal-type gastric carcinoma: co-localization with β-catenin and correlation with poor prognosis
por: Wang, Lei, et al.
Publicado: (2015)

UBE2V2 promotes metastasis by regulating EMT and predicts a poor prognosis in lung adenocarcinoma
por: Yang, Zheng, et al.
Publicado: (2023)

CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
por: Jiang, Guoqing, et al.
Publicado: (2016)

Loss of PR55α promotes proliferation and metastasis by activating MAPK/AKT signaling in hepatocellular carcinoma
por: Zhao, JiangSheng, et al.
Publicado: (2021)

MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis
por: Li, Yue, et al.
Publicado: (2017)

Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer
por: Peng, Chen, et al.
Publicado: (2020)

Overexpression of GPX3, a potential biomarker for diagnosis and prognosis of breast cancer, inhibits progression of breast cancer cells in vitro
por: Lou, Weiyang, et al.
Publicado: (2020)

The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data
por: Mo, Chao-hua, et al.
Publicado: (2017)

Correction: Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2022)

A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer
por: Zhang, Chen, et al.
Publicado: (2020)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma
por: Shen, Zhenghai, et al.
Publicado: (2017)

Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation
por: Lin, Xia-Hui, et al.
Publicado: (2023)

Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma
por: Cai, Weiyang, et al.
Publicado: (2021)

CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis
por: Dou, Dongwei, et al.
Publicado: (2020)

A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma
por: Ouyang, Guoqing, et al.
Publicado: (2020)

Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma
por: Wu, Gang, et al.
Publicado: (2015)

High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer
por: Zhao, Zongxian, et al.
Publicado: (2021)

Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer
por: Zhao, Tianyi, et al.
Publicado: (2021)

Expression of the Wnt ligands gene family and its relationship to prognosis in hepatocellular carcinoma
por: Dong, Jia-Jia, et al.
Publicado: (2019)

Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma
por: Guo, Lingyun, et al.
Publicado: (2020)

High AKAP8L expression predicts poor prognosis in esophageal squamous cell carcinoma
por: Luo, Qiu-yun, et al.
Publicado: (2022)

LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
por: He, Rong-Quan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d5l24f274o3e7ci1vhsqqkm7bi